Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 3/20 | 0.38 |
| ▸ | PPARG | P37231 | 2/20 | 0.38 |
| ▸ | BID | P55957 | 6/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 6/20 | 0.35 |
| ▸ | BCL2L1 | Q07817 | 5/20 | 0.35 |
| ▸ | BAK1 | Q16611 | 5/20 | 0.35 |
| ▸ | F7 | P08709 | 3/20 | 0.35 |
| ▸ | F3 | P13726 | 3/20 | 0.35 |
| ▸ | MMP2 | P08253 | 2/20 | 0.35 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | ECE1 | P42892 | 1/20 | 0.35 |
| ▸ | SGMS1 | Q86VZ5 | 1/20 | 0.35 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.35 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.34 |
| ▸ | EP300 | Q09472 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL380175 | 0.80 | — | — | |
| SCHEMBL27259266 | 0.76 | FOLH1 (0.45) | PPARAPPARGBIDMCL1BCL2L1 | |
| SCHEMBL985791 | 0.75 | THRA (0.48) | HSD17B10THRATHRBALDH1A1LMNA | |
| Acetic Acid SCHEMBL12469814 | 0.75 | NR1H4 (0.31) | — | |
| SCHEMBL30026525 | 0.73 | THRB (0.37) | THRATHRBL3MBTL1 | |
| SCHEMBL4211496 | 0.73 | BID (0.58) | PPARAPPARGBIDMCL1BCL2L1 | |
| SCHEMBL247553 | 0.73 | SLC7A5 (0.31) | — | |
| SCHEMBL27776540 | 0.73 | BID (0.50) | PPARAPPARGBIDMCL1BCL2L1 | |
| SCHEMBL4211495 | 0.73 | BID (0.50) | PPARAPPARGBIDMCL1BCL2L1 | |
| Acrylic Acid SCHEMBL9769683 | 0.72 | PTGER4 (0.40) | KDM4EMAPTHSD17B10ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0845255-B1 | Aquous dispersion of vesicles resistant to dehydration | OREAL (FR) | 2002-03-13 | — | — | EP | claimed |
| US-6022559-A | COSMETIC OR PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION BASED ON SUCH A DISPERSION FOR COSMETIC OR DERMATOLOGICAL TREATMENT OF THE SKIN | L'OREAL (FR) | 2000-02-08 | — | — | US | claimed |
| US-9238078-B2 | Modified-release pharmaceutical drug composition | COATING PLACE, INC. (US) | 2016-01-19 | — | — | US | disclosed |
| US-9125948-B2 | Ion exchange resin treated to control swelling | COATING PLACE, INC. (US) | 2015-09-08 | — | — | US | disclosed |
| US-8883213-B2 | Ion exchange resin treated to control swelling | COATING PLACE, INC. (US) | 2014-11-11 | — | — | US | disclosed |
| US-8343546-B2 | Ion exchange resin treated to control swelling | COATING PLACE, INC. (US) | 2013-01-01 | — | — | US | disclosed |
| US-8329224-B2 | Ion exchange resin treated to control swelling | COATING PLACE, INC. (US) | 2012-12-11 | — | — | US | disclosed |
| US-20120064167-A1 | MODIFIED-RELEASE PHARMACEUTICAL DRUG COMPOSITION | COATING PLACE, INC. (US) | 2012-03-15 | — | — | US | disclosed |
| EP-2413898-A1 | MODIFIED-RELEASE PHARMACEUTICAL DRUG COMPOSITION | Coating Place, Inc. (US) | 2012-02-08 | — | — | EP | disclosed |
| US-20110081419-A1 | ION EXCHANGE RESIN TREATED TO CONTROL SWELLING | COATING PLACE, INC. | 2011-04-07 | — | — | US | disclosed |
| US-20110076385-A1 | ION EXCHANGE RESIN TREATED TO CONTROL SWELLING | COATING PLACE, INC. | 2011-03-31 | — | — | US | disclosed |
| US-7871645-B2 | Loading one or more drugs in a solution onto one or more ion exchange resin particles to form a drug-loaded resin particle which is separated from the solution and dried before recombining the drug-loaded resin particle with the solution to load more drugs onto the drug-load; controlled release | COATING PLACE, INC. (US) | 2011-01-18 | — | — | US | disclosed |
| WO-2010115015-A1 | MODIFIED-RELEASE PHARMACEUTICAL DRUG COMPOSITION | COATING PLACE, INC. (US) | 2010-10-07 | — | — | WO | disclosed |
| EP-1931312-A2 | ION EXCHANGE RESIN TREATED TO CONTROL SWELLING | Coating Place, Inc. (US) | 2008-06-18 | — | — | EP | disclosed |
| US-20070148239-A1 | Loading one or more drugs in a solution onto one or more ion exchange resin particles to form a drug-loaded resin particle which is separated from the solution and dried before recombining the drug-loaded resin particle with the solution to load more drugs onto the drug-load; controlled release | COATING PLACE, INC. (US) | 2007-06-28 | — | — | US | disclosed |
| US-20070140983-A1 | Loading one or more drugs in a solution onto one or more ion exchange resin particles to form a drug-loaded resin particle which is separated from the solution and dried before recombining the drug-loaded resin particle with the solution to load more drugs onto the drug-load; controlled release | COATING PLACE, INC. (US) | 2007-06-21 | — | — | US | disclosed |
| WO-2007033281-A2 | ION EXCHANGE RESIN TREATED TO CONTROL SWELLING | COATING PLACE, INC. (US) | 2007-03-22 | — | — | WO | disclosed |
| US-20070059270-A1 | Loading one or more drugs in a solution onto one or more ion exchange resin particles to form a drug-loaded resin particle which is separated from the solution and dried before recombining the drug-loaded resin particle with the solution to load more drugs onto the drug-load; controlled release | THE COATING PLACE, INC. (US) | 2007-03-15 | — | — | US | disclosed |